カテゴリ： MarketLine, マレーシア, 企業調査

Liberty Insurance Berhad：企業の戦略・SWOT・財務情報

◆英語タイトル：Liberty Insurance Berhad - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C1178
◆発行会社（調査会社）：MarketLine
◆発行日：2018年7月
◆ページ数：21
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：マレーシア
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Liberty Insurance Berhad – Strategy, SWOT and Corporate Finance Report
Summary

Liberty Insurance Berhad – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Liberty Insurance Berhad (Liberty Insurance), formerly Uni.Asia General Insurance Berhad, is a general insurance company. It provides a range of non-life insurance products to individuals and corporate customers. Its offerings include motor insurance, business insurance, health insurance, personal insurance, marine cargo insurance, travel insurance, driver and passenger insurance, workers’ compensation insurance and engineering insurance. It also offers insurance products for home, liability, all risks and property. The company markets and distributes products through branch offices, general agents, franchise holders, POS outlets, car dealers, and bank partners in Malaysia. Liberty Insurance is a subsidiary of LibertySeguros, Compania de Seguros y Reaserguros, S.A. It is headquartered in Kuala Lumpur, Malaysia.

The company reported gross premiums written of MYR651.8 million for the fiscal year ended December 2017 (FY2017), a decline of 4.6% over that in FY2016. Its net premium written was MYR556.1 million in FY2017, a decline of 12.1% over that in FY2016.

Scope

- Detailed information on Liberty Insurance Berhad required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Liberty Insurance Berhad in the form of a SWOT analysis
- An in-depth view of the business model of Liberty Insurance Berhad including a breakdown and examination of key business segments
- Intelligence on Liberty Insurance Berhad’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Liberty Insurance Berhad, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Liberty Insurance Berhad and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Liberty Insurance Berhad as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Liberty Insurance Berhad’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Liberty Insurance Berhad: Company Overview 6
Liberty Insurance Berhad: Overview and Key Facts 6
Liberty Insurance Berhad: Overview 6
Liberty Insurance Berhad: Key Facts 6
Liberty Insurance Berhad: Key Employees 8
Liberty Insurance Berhad: Major Products and Services 9
Liberty Insurance Berhad: Company History 10
Liberty Insurance Berhad: Management Statement 12
Liberty Insurance Berhad: Locations and Subsidiaries 13
Liberty Insurance Berhad: Key Competitors 14
Liberty Insurance Berhad: Company Analysis 15
Liberty Insurance Berhad: Business Description 15
Liberty Insurance Berhad: SWOT Analysis 16
Liberty Insurance Berhad: SWOT Overview 16
Liberty Insurance Berhad: Strengths 16
Liberty Insurance Berhad: Weaknesses 16
Liberty Insurance Berhad: Opportunities 17
Liberty Insurance Berhad: Threats 17
Appendix 19
Contact Us 19
Methodology 19
About MarketLine 20

List of Tables
Table 1: Liberty Insurance Berhad: Key Facts
Table 2: Liberty Insurance Berhad: Key Employees
Table 3: Liberty Insurance Berhad: Locations and Subsidiaries
Table 4: Liberty Insurance Berhad: Key Competitors



★海外企業調査レポート[Liberty Insurance Berhad：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Sandoz International GmbH：企業の戦略・SWOT・財務分析
    Sandoz International GmbH - Strategy, SWOT and Corporate Finance Report Summary Sandoz International GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Posco Daewoo Corporation (047050)-石油・ガス分野：企業M&A・提携分析
    Summary Posco Daewoo Corporation (Posco Daewoo), formally known as Daewoo International Corporation, is an international trading and investment company. It is involved in international trade, resource development and project organizing businesses. The company’s operational activities include export …
  • AbCheck sro：製薬・医療：M&Aディール及び事業提携情報
    Summary AbCheck Sro (AbCheck), a subsidiary of Affimed NV is a healthcare technology company offers discovery and optimization of high-quality human antibodies. The company offers technology platforms such as Absieve, and AbAccel. Its Absieve is an antibody discovery technology that offers proprieta …
  • genedrive plc (GDR)-製薬・医療分野：企業M&A・提携分析
    Summary genedrive plc (genedrive), formerly Epistem Holdings plc is a molecular diagnostics company. The company focuses on the development and commercialization of simple to use “point of need” system or point of care diagnostics platform for the diagnosis of infectious diseases and use in patient …
  • Achelios Therapeutics Inc-製薬・医療分野：企業M&A・提携分析
    Summary Achelios Therapeutics Inc (Achelios) is a biopharmaceutical development company that provides reformulation of non-steroidal anti-inflammatory (NSAID) drug molecules. The company offers therapeutic entity development for the treatment of pain and inflammation. Its lead product includes Topof …
  • Engie S.A.：企業のM&A・事業提携・投資動向
    Engie S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Engie S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Hindustan Aeronautics Ltd：企業の戦略・SWOT・財務情報
    Hindustan Aeronautics Ltd - Strategy, SWOT and Corporate Finance Report Summary Hindustan Aeronautics Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Spectrum Brands Holdings Inc (SPB)：企業の財務・戦略的SWOT分析
    Spectrum Brands Holdings Inc (SPB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • University of Toronto-製薬・医療分野：企業M&A・提携分析
    Summary University of Toronto (UT) is an educational and research service provider that offers undergraduate and postgraduate courses in various fields. The university offers courses in various fields such as applied science and engineering, architecture, landscape, design, arts and science, continu …
  • SMART Medical Systems Ltd-医療機器分野：企業M&A・提携分析
    Summary Smart Medical Systems Ltd (Smart) is a medical device company that develops and manufactures medical equipment in the field of gastroenterology and GI endoscopy. The company offers products such as inflation systems, platform, naviaid ABC, G-eye, naviaid AB, future naviaid products, controll …
  • Vallourec SA：企業のM&A・事業提携・投資動向
    Vallourec SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vallourec SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • PT Kimia Farma (KAEF)：企業の財務・戦略的SWOT分析
    PT Kimia Farma (KAEF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bioactive Bone Substitutes Plc (BONEH)：企業の製品パイプライン分析
    Summary Bioactive Bone Substitutes Plc (BBS) is a health technology company that manufactures biologically active medical device implants for orthopedic surgery. The company provides technology platforms, artebone, research and development, patents, and others. It offers artebone which is made up of …
  • Humanwell Healthcare (Group) Co Ltd (600079)：製薬・医療：M&Aディール及び事業提携情報
    Summary Humanwell Healthcare (Group) Co Ltd (Humanwell), formerly Wuhan Humanwell Hi-Tech Industry Co Ltd is a pharmaceutical company that offers generic products. The company offers pharmaceutical, medical instrument and reproductive health care products and technologies. Its products include anest …
  • Ohr Pharmaceutical Inc (OHRP)：企業の財務・戦略的SWOT分析
    Summary Ohr Pharmaceutical Inc (Ohr), formerly BBM Holdings Inc, is a pharmaceutical company that develops novel therapies for ophthalmic diseases. The company offers products such as squalamine lactate ophthalmic solution and SKS sustained release technology products. Its squalamine lactate ophthal …
  • Zealand Pharma AS (ZEAL)：製薬・医療：M&Aディール及び事業提携情報
    Summary Zealand Pharma AS (Zealand) is a biotechnology company that discovers, designs and develops peptide based medicines that targets specialty diseases. The company’s marketed products comprise Lyxumia and Suliqua for the treatment of Type 2 diabetes and others for the treatment of obesity and f …
  • PharmaCyte Biotech Inc (PMCB)：製薬・医療：M&Aディール及び事業提携情報
    Summary PharmaCyte Biotech Inc (PharmaCyte), formerly Nuvilex Inc, is a clinical stage biotechnology company that develops and commercializes treatments for cancer and diabetes. The company offers technology is used for the treatment of advanced and inoperable pancreatic cancer and diabetes. It deve …
  • Cogstate Ltd (CGS)：医療機器：M&Aディール及び事業提携情報
    Summary Cogstate Ltd (Cogstate) is a cognitive science company that provides technology solutions. The company offers scientific consulting, precision recruitment and computerized assessment, among others. It also provides drug development strategies, protocol design, test selection for screening, s …
  • Histocell SL：製薬・医療：M&Aディール及び事業提携情報
    Summary Histocell SL (Histocell), a subsidiary of Noray Biosciences Group, is a biopharmaceutical company that develops cell therapy and tissue engineering products for regenerative medicine. The company provides Wharton Gel Complex, medical devices, contract manufacturing and cell therapy programs, …
  • Capsugel Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Capsugel Inc (Capsugel) is a contract manufacturing company which designs, develops and manufactures a range of innovative dosage forms. It provides contract services to the biopharmaceutical and consumer health and nutrition industries. The company’s services enable clients to enhance the b …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆